Loading stock data…
DuPont de Nemours (DD)
$135.74-1.48 (-1.08%)
After Hours$135.74+0.00 (+0.00%)· Last close Jun 29
DuPont de Nemours, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
DuPont de Nemours, Inc. in the Basic Materials sector is trading at $135.74 with a market capitalization of $19.6B. Wall Street consensus targets $170.81 (16 analysts), implying a +25.8% move over the next 12 months. The stock is currently 14% below its 52-week high of $157.98, remaining 6.6% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +25.8% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.68B↑ | -$1.87B↓ | $3.07B↓ | $3.26B↑ | $1.61B |
| Gross Profit | $602.00M↑ | -$1.05B↓ | $1.20B↓ | $1.22B↑ | $543.00M |
| Operating Income | $232.00M↑ | -$652.00M↓ | $547.00M↑ | $529.00M↑ | $184.00M |
| Net Income | $161.00M↑ | -$126.00M↓ | -$123.00M↓ | $59.00M↑ | -$589.00M |
Peer Comparison
Fundamentals
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Divers...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$19.56B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.42%
ROE
Average efficiency. Growth may require heavy reinvestment.
-0.21%
Volume
Today's trading volume
1.60M
Recent News
Chemours to pay $450M in first federal "forever chemicals" settlement
Chemical maker Chemours allegedly discharged chemicals linked to cancer and other health conditions in three states.
Jim Cramer Believes “Qnity’s Basically a Bet on the Future of Chip-Making”
Qnity Electronics, Inc. (NYSE:Q) was among the stocks Jim Cramer discussed as he said that the Iran peace negotiations could trigger an oil glut, cool inflation, and pull interest rates down. Cramer highlighted the sharp rise in the company’s stock price, as he commented: I don’t think people understand the scale or scope of the […]
What Honeywell’s and DuPont’s Coming Reverse Stock Splits Mean for Investors
Two major industrial restructurings are about to reshape share counts at DuPont de Nemours (NYSE: DD) and Honeywell (NASDAQ: HON). Both companies have confirmed reverse stock splits tied to portfolio breakups rather than fundamental valuation shifts. Here is what changes for shareholders. DuPont executes a 1-for-3 reverse split effective 12:01 a.m. ET on June 24, ... What Honeywell’s and DuPont’s Coming Reverse Stock Splits Mean for Investors
Top 3D Printing Stocks to Buy Now for Solid Long-Term Returns
3D Printing is reshaping industries with faster production and lower costs, drawing investor interest. Stocks like DD, PRLB, AME and ATI offer strong growth potential.
Here Are Monday’s Best Wall Street Analyst Research Calls: Accenture, Caesars Entertainment, Datadog, DuPont, EPAM Systems, Ferrari, Paychex, Rocket Lab, TeraWulf, and More
Pre-Market Stock Futures: Futures are exploding higher on news of a peace deal with Iran expected to be signed this Friday. This follows a historic Friday that saw the coming-out party of Space Exploration Technologies (NASDAQ: SPCX), widely known as Elon Musk’s SpaceX. The record-breaking size of the offering, raising $75 billion, the company’s debut ... Here Are Monday’s Best Wall Street Analyst Research Calls: Accenture, Caesars Entertainment, Datadog, DuPont, EPAM Systems, Ferrari, Paychex,